Nevro (NYSE: NVRO) is a public multinational medical technology company headquartered in Redwood City, California. We have developed HF10™ therapy, an innovative, evidence-based neuromodulation platform.
We started with a simple mission to help more patients suffering from chronic pain. At each stage of development, our research was subject to the highest levels of scientific rigor, resulting in a new therapy that has impacted the lives of over 28,000 patients around the world.
The Nevro® Senza® SCS System received CE mark in 2010, TGA approval in 2011, FDA approval in 2015, and is commercially available in Europe, Australia, and the United States.
This position will be responsible for maintenance of US & OUS regulatory files and publication library. This position will also be responsible for providing support to the regulatory team in preparing submission. In addition, the intern will be spending a lot of time helping us get prepared for the new EU MDRs, I see BSI kind of pushing companies to start implementing the regulations even sooner than deadline. This position works directly with regulatory.